Literature DB >> 25091809

Sample size calculations for prevalent cohort designs.

Hao Liu1, Yu Shen2, Jing Ning2, Jing Qin3.   

Abstract

Cross-sectional prevalent cohort design has drawn considerable interests in the studies of association between risk factors and time-to-event outcome. The sampling scheme in such design gives rise to length-biased data that require specialized analysis strategy but can improve study efficiency. The power and sample size calculation methods are however lacking for studies with prevalent cohort design, and using the formula developed for traditional survival data may overestimate sample size. We derive the sample size formulas that are appropriate for the design of cross-sectional prevalent cohort studies, under the assumptions of exponentially distributed event time and uniform follow-up for cross-sectional prevalent cohort design. We perform numerical and simulation studies to compare the sample size requirements for achieving the same power between prevalent cohort and incident cohort designs. We also use a large prospective prevalent cohort study to demonstrate the procedure. Using rigorous designs and proper analysis tools, the prospective prevalent cohort design can be more efficient than the incident cohort design with the same total sample sizes and study durations.

Entities:  

Keywords:  incident cohort design; length-biased data; prevalent cohort design; sample size determination; survival data

Mesh:

Year:  2016        PMID: 25091809      PMCID: PMC4317376          DOI: 10.1177/0962280214544730

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  18 in total

Review 1.  Sample size calculations for randomized controlled trials.

Authors:  Janet Wittes
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Pseudo-partial likelihood for proportional hazards models with biased-sampling data.

Authors:  Wei Yann Tsai
Journal:  Biometrika       Date:  2009-06-24       Impact factor: 2.445

3.  Nonparametric tests for right-censored data with biased sampling.

Authors:  Jing Ning; Jing Qin; Yu Shen
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2010-11-01       Impact factor: 4.488

4.  Considerable differences exist between prevalent and incident myocardial infarction cohorts derived from the same population.

Authors:  Brian S Buckley; Colin R Simpson; David J McLernon; Philip C Hannaford; Andrew W Murphy
Journal:  J Clin Epidemiol       Date:  2010-05-14       Impact factor: 6.437

5.  Introduction to sample size determination and power analysis for clinical trials.

Authors:  J M Lachin
Journal:  Control Clin Trials       Date:  1981-06

6.  Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.

Authors:  J M Lachin; M A Foulkes
Journal:  Biometrics       Date:  1986-09       Impact factor: 2.571

7.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

8.  Statistical models for prevalent cohort data.

Authors:  M C Wang; R Brookmeyer; N P Jewell
Journal:  Biometrics       Date:  1993-03       Impact factor: 2.571

9.  Statistical methods for analyzing right-censored length-biased data under cox model.

Authors:  Jing Qin; Yu Shen
Journal:  Biometrics       Date:  2009-06-12       Impact factor: 2.571

10.  The prevalent cohort study and the acquired immunodeficiency syndrome.

Authors:  R Brookmeyer; M H Gail; B F Polk
Journal:  Am J Epidemiol       Date:  1987-07       Impact factor: 4.897

View more
  2 in total

1.  Factors associated with post NICU discharge exclusive breastfeeding rate and duration amongst first time mothers of preterm infants in Shanghai: a longitudinal cohort study.

Authors:  Xin Jiang; Hui Jiang
Journal:  Int Breastfeed J       Date:  2022-05-02       Impact factor: 3.790

2.  Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial).

Authors:  Qi Wei; Yang Wang; Yong-Bo An; Zheng-Yang Yang; Yi-Shan Liu; Xiao Zhang; Zhi-Chun Gu; Hong-Wei Yao
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.